Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
18 March 2024
Labor & Employment Law Perspectives
Drafting Non-Competes in a Shifting Regulatory Landscape
As our readers are aware, we have been tracking the ongoing trend of restricting employee non-compete agreements by various states and the federal government, including the FTC and NLRB.
18 March 2024
Labor & Employment Law Perspectives
Eleventh Circuit Finds Volunteer Golf Attendants Not Entitled to Compensation Under the FLSA
On March 12, 2024, the U.S. Court of Appeals for the Eleventh Circuit affirmed the dismissal of a putative class action wage and hour lawsuit brought by three golf course attendants who signed up to volunteer at a golf course operated by Palm Beach County, Florida.
18 March 2024
Foley Career Perspectives
Investing in Our Attorneys Over the Arc of Their Careers
Other firms plan for attrition … at Foley, we plan for careers.